For how PrEP works, dosing protocols (daily, on-demand 2-1-1, injectable), and what to expect medically, read PrEP Mechanics: Daily, On-Demand & Injectable first. This guide covers the European-specific picture: who pays, how to access it, and what's currently available where.
Cost & Coverage
The cost of PrEP varies dramatically depending on the national health system.
- Fully Covered: In many Western and Northern European countries, PrEP is free or heavily subsidized through the public health system.
- Out-of-Pocket: In several Eastern and Southern European countries, PrEP may only be available privately, requiring out-of-pocket payment for both the medication and the necessary medical monitoring.
Check the specific country guide to understand the exact access routes and financial support available in your location. Most countries require confirmed HIV-negative status and, in some cases, a documented risk profile. Your local sexual health clinic can confirm eligibility criteria.
Generics: The Route Around High Cost
Brand-name Truvada is expensive across the continent when not publicly funded. Generic TDF/FTC (e.g., Tenvir-EM) is chemically identical and significantly cheaper. If you're paying privately, ask specifically for generics.
On-demand 2-1-1 dosing is only validated for TDF/FTC (Truvada and generics). Descovy (TAF/FTC) must be taken daily. See PrEP Mechanics for full protocol detail.
How to Access PrEP in Europe
Sexual health clinic (recommended): The standard route in every EU country. Often free or covered. Waiting lists of weeks to months in busier cities are common — call ahead.
Online / telemedicine: Services operating from countries with subsidised PrEP (France, UK) sometimes serve EU patients via video consultation + local bloodwork. Faster than waiting lists but regulatory status varies by home country. You take on responsibility for monitoring.
Cross-border prescription: Technically permitted under EU law but pharmacies in your home country may refuse to fill a foreign prescription. Works inconsistently in practice.
Private purchase: Last resort. Prices for generics vary significantly depending on source. No built-in medical supervision; you manage your own monitoring.
Injectable PrEP (Cabotegravir / Apretude) in Europe
Cabotegravir received EMA approval and is rolling out across Europe. Two loading injections one month apart, then once every two months.
Current status varies widely across member states. It is actively available in several Western European countries but remains limited or unavailable in much of Central and Eastern Europe.
Ask your sexual health clinic whether it's available in your area. See PrEP Mechanics for the startup protocol and the important note on stopping injectable PrEP safely.
Related: